Imaging of ABC transporter function and expression

Current Topics in Medicinal Chemistry

Volumn 10, Issue 17, 2010, Pages 1701-1702

  Colabufo, Nicola Antonio ^a   van Waarde, Aren ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER;

EDITORIAL; IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CHEMISTRY, PHARMACEUTICAL; HUMANS; INFLAMMATION MEDIATORS; NEOPLASMS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 77958000666     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802610792928068     Document Type: Editorial

References (12)

1. Colabufo NA, Berardi F, Perrone MG, Capparelli E, Cantore M, Inglese C, and Perrone R. Substrates, inhibitors and activators of P-glycoprotein: Candidates for radiolabeling and imaging perspectives. Curr Top Med Chem 2010; 10(17): 1703-1714.
2. Teodori E, Dei S, Martelli C, and Scapecchi S. N,N-bis(Cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR). Curr Top Med Chem 2010; 10(17): 1715-1731.
3. Yang AK, Zhou ZW, Wei MQ, Liu JP, and Zhou SF. Modulators of multidrug resistance associated proteins in the management of anticancer and antimicrobial drug resistance and the treatment of inflammatory diseases. Curr Top Med Chem 2010; 10(17): 1732-1756.
4. Molnár J, Engi H, Hohmann J, Molnár P, Deli J, Wesolowska O, Michalak K, and Wang Q. Reversal of multidrug resistance by natural substances from plants. Curr Top Med Chem 2010; 10(17): 1757-1768.
5. Klepsch F, Stockner T, Erker T, Müller M, Chiba P and Ecker GF. Using structural and mechanistic information to design novel inhibitors/substrates of P-glycoprotein. Curr Top Med Chem 2010; 10(17): 1769-1774.
6. 11C-Verapamil to assess P-glycoprotein function in human brain during aging, depression and neurodegenerative disease. Curr Top Med Chem 2010; 10(17): 1775-1784.
7. Löscher W, and Langer O. Imaging of P-glycoprotein function and expression to elucidate mechanisms of pharmacoresistance in epilepsy. Curr Top Med Chem 2010; 10(17): 1785-1791.
8. 18F-fluoropaclitaxel. Curr Top Med Chem 2010; 10(17): 1792-1798.
9. Syvänen S, and Hammarlund-Udenaes M. Using PET studies of P-glycoprotein function to elucidate mechanisms underlying the disposition of drugs. Curr Top Med Chem 2010; 10(17): 1799-1809.
10. Okamura T, Kikuchi T, and Irie T. PET imaging of MRP1 function in the living brain: Method development and clinical perspectives. Curr Top ed Chem 2010; 10(17): 1810-1819.
11. Luurtsema G, Verbeek J, Lubberink M, Lammertsma AA, Dierckx RA, Elsinga PH, Windhorst B, and van Waarde A. Overview of carbon-11- abeled tracers for probing P-glycoprotein function: kinetics, advantages and disadvantages. Curr Top Med Chem 2010; 10(17): 1820-1833.
12. Piwnica-Worms D, and Sharma V. Probing multidrug resistance P-glycoprotein transporter activity with SPECT radiopharmaceuticals. Curr Top Med Chem 2010; 10(17): 1834-1845.